Docetaxel: A Pharmacoeconomic Review of its Use in the Treatment of Metastatic Breast Cancer

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.14, Iss.4, 1998-10, pp. : 447-459

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel: A Review of its Use in Metastatic Breast Cancer

By Lyseng-Williamson Katherine A. Fenton Caroline

Drugs, Vol. 65, Iss. 17, 2005-01 ,pp. : 2513-2531

Adis International

Access to resources Recommend Favorite

Trastuzumab: A Pharmacoeconomic Review of its Use in Early Breast Cancer

By McKeage Kate Lyseng-Williamson Katherine A.

PharmacoEconomics, Vol. 26, Iss. 8, 2008-01 ,pp. : 699-719

Adis International

Access to resources Recommend Favorite

Letrozole: A Pharmacoeconomic Review of its Use in Postmenopausal Women with Breast Cancer

By Dunn Christopher Keam Susan J.

PharmacoEconomics, Vol. 24, Iss. 5, 2006-01 ,pp. : 495-517

Adis International

Access to resources Recommend Favorite

Paclitaxel: A Pharmacoeconomic Review of its Use in the Treatment of Ovarian Cancer

By Young M. Plosker G.L.

PharmacoEconomics, Vol. 19, Iss. 12, 2001-01 ,pp. : 1227-1259

Adis International

Access to resources Recommend Favorite

Trastuzumab: A Review of its Use in the Treatment of Metastatic Breast Cancer Overexpressing HER2

By McKeage K. Perry C.M.

Drugs, Vol. 62, Iss. 1, 2002-01 ,pp. : 209-243

Adis International

Access to resources Recommend Favorite